&nbsp;

Sep 2024

Drug

Kadcyla trastuzumab emtansine

Other Name(s): Kadcyla®

Quick Link(s):

Aug 2023

Drug

romidepsin

Other Name(s): Istodax®

Quick Link(s):

Mar 2023

Drug

ramucirumab

Other Name(s): Cyramza®

Quick Link(s):

Mar 2023

Regimen

KADC

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Trastuzumab Emtansine - Unresectable Locally Advanced or Metastatic Breast Cancer

Kadcyla trastuzumab emtansine

Drugs Used:

Quick Link(s):

Regimen Monograph

Aug 2023

Regimen

RALT

Cancer Type:

Gastrointestinal,

Colorectal,

Esophagus,

Gastric / Stomach,

Small bowel and appendix

Intent: Adjuvant, Palliative

Funding:

New Drug Funding Program

Raltitrexed - Metastatic Colorectal Small Bowel or Appendiceal Cancer

New Drug Funding Program

Raltitrexed - Metastatic Esophageal, Gastroesophageal Junction, or Gastric Cancer

New Drug Funding Program

Raltitrexed - Adjuvant Colorectal, Small Bowel, or Appendiceal Cancer

New Drug Funding Program

Raltitrexed - Adjuvant Esophageal, Gastroesophageal Junction, or Gastric Cancer

Drugs Used:

raltitrexed

Quick Link(s):

Regimen Monograph

Jun 2024

Drug

radium-223

Other Name(s): Xofigo®

Quick Link(s):

Drug Monograph

Jun 2019

Regimen

KADC

Cancer Type:

Breast

Intent: Adjuvant

Funding:

New Drug Funding Program

Trastuzumab Emtansine - Adjuvant Treatment for Early Breast Cancer

Kadcyla trastuzumab emtansine

Drugs Used:

Quick Link(s):

Regimen Monograph

Oct 2023

Drug

riTUXimab

Other Name(s): Rituxan® , Truxima™ , Riximyo™ , Ruxience™ , Riabni™

Quick Link(s):

Updated

Jun 2025

Drug

riTUXimab (subcut)

Other Name(s): Rituxan® SC

Quick Link(s):

Updated

Jun 2025

Regimen

RITU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Rituximab (Biosimilar IV) - Single Agent - Indolent Lymphoma

Drugs Used:

riTUXimab

Quick Link(s):

Regimen Monograph

Updated

Jun 2025

Regimen

RITU(MNT)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Maintenance Treatment - Lymphoma

Drugs Used:

riTUXimab